Literature DB >> 21460750

MicroRNA miR-125b induces senescence in human melanoma cells.

Martin Glud1, Valentina Manfé, Edyta Biskup, Line Holst, Anne Marie Ahlburg Dirksen, Nina Hastrup, Finn C Nielsen, Krzysztof T Drzewiecki, Robert Gniadecki.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules involved in gene regulation. Aberrant expression of miRNA has been associated with the development or progression of several diseases, including cancer. In a previous study, we found that the expression of miRNA-125b (miR-125b) was two-fold lower in malignant melanoma producing lymph node micrometastases than in nonmetastasizing tumors. To get further insight into the functional role of miR-125b, we assessed whether its overexpression or silencing affects apoptosis, proliferation, or senescence in melanoma cell lines. We showed that overexpression of miR-125b induced typical senescent cell morphology, including increased cytoplasmatic/nucleus ratio and intensive cytoplasmatic β-galactosidase expression. In contrast, inhibition of miR-125b resulted in 30-35% decreased levels of spontaneous apoptosis. We propose that downregulation of miR-125b in an early cutaneous malignant melanoma can contribute to the increased metastatic capability of this tumor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460750     DOI: 10.1097/CMR.0b013e328345333b

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  19 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

2.  Inference of Target Gene Regulation via miRNAs during Cell Senescence by Using the MiRaGE Server.

Authors:  Y-H Taguchi
Journal:  Aging Dis       Date:  2012-06-07       Impact factor: 6.745

3.  Analysis of sentinel node positivity in primary cutaneous melanoma: an 8-year single institution experience.

Authors:  K M Joyce; N M McInerney; R P Piggott; F Martin; D M Jones; A J Hussey; M J Kerin; J L Kelly; P J Regan
Journal:  Ir J Med Sci       Date:  2017-01-28       Impact factor: 1.568

Review 4.  MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.

Authors:  Miguel F Segura; Holly S Greenwald; Doug Hanniford; Iman Osman; Eva Hernando
Journal:  Carcinogenesis       Date:  2012-06-12       Impact factor: 4.944

Review 5.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

6.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

Review 7.  The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.

Authors:  Angeline A Giangreco; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2013-01-16       Impact factor: 4.292

Review 8.  Control by a hair's breadth: the role of microRNAs in the skin.

Authors:  Matthew S Ning; Thomas Andl
Journal:  Cell Mol Life Sci       Date:  2012-09-15       Impact factor: 9.261

9.  MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation.

Authors:  Ana O'Loghlen; Ana M Muñoz-Cabello; Alexandre Gaspar-Maia; Hsan-Au Wu; Ana Banito; Natalia Kunowska; Tomas Racek; Helen N Pemberton; Patrizia Beolchi; Fabrice Lavial; Osamu Masui; Michiel Vermeulen; Thomas Carroll; Johannes Graumann; Edith Heard; Niall Dillon; Veronique Azuara; Ambrosius P Snijders; Gordon Peters; Emily Bernstein; Jesus Gil
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

10.  A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.

Authors:  Jos B Poell; Rick J van Haastert; Thijs de Gunst; Iman J Schultz; Willemijn M Gommans; Mark Verheul; Francesco Cerisoli; Andre A F L van Puijenbroek; Paula I van Noort; Gregoire P Prevost; Roel Q J Schaapveld; Edwin Cuppen
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.